ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,942.47
1.26%
Dow Jones
42,732.13
0.80%
US Dollar vs MXN
20.41521
-1.04%
Brent Oil
76.74
0.31%
Bitcoin
99,305.23
0.99%
Pepperstone
Advertisement
Registration Strip Icon for monitor Monitoree múltiples cotizaciones en tiempo real de los principales intercambios, como la Bolsa de Valores de Londres, NASDAQ, NYSE, AMEX, Bovespa y más.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. USOTC

  6. Daiichi Sankyo Company Ltd (PK) (DSNKY) Cotización

Daiichi Sankyo Company Ltd (PK)

Daiichi Sankyo Company Ltd (PK) (DSNKY)

USOTC
27.40
0.00
(0.00%)
Cerrado 06 Enero 3:00PM
Delayed by 15 minutes

Herramientas de nivel profesional para inversores individuales.

Premium

Estadísticas y detalles clave

Último Precio
27.40
Postura de Compra
25.75
Postura de Venta
27.50
Volume Operado de la Acción
-
0.00 Rango del Día 0.00
26.80 Rango de 52 semanas 42.48
Precio Anterior
27.40
Precio de Apertura
-
Hora
Última hora de negociación
Volumen promedio (3 m)
143,418
Volumen financiero
-
Precio Promedio Ponderado
-

DSNKY Últimas noticias

Más noticias

Daiichi Sankyo's Once-Daily Lixiana® (edoxaban) Approved for the Prevention of Stroke and Systemic Embolism in Non-Valvular ...

Daiichi Sankyo's Once-Daily Lixiana® (edoxaban) Approved for the Prevention of Stroke and Systemic Embolism in Non-Valvular Atrial Fibrillation and for the Treatment and Prevention of Recurrent...

15 Abril 2015
PR Newswire (US)

Daiichi Sankyo, Inc. and Asubio Pharmaceuticals, Inc. Merge

Daiichi Sankyo, Inc. and Asubio Pharmaceuticals, Inc. Merge PR Newswire PARSIPPANY, N.J., April 1, 2015 PARSIPPANY, N.J., April 1, 2015 /PRNewswire/ -- Daiichi Sankyo, Inc., the US subsidiary of...

01 Abril 2015
PR Newswire (US)

Daiichi Sankyo and Ambit Announce Results of Tender Offer

Daiichi Sankyo and Ambit Announce Results of Tender Offer PR Newswire TOKYO and SAN DIEGO, Nov. 10, 2014 TOKYO and SAN DIEGO, Nov. 10, 2014 /PRNewswire/ -- Daiichi Sankyo Company, Limited...

10 Noviembre 2014
PR Newswire (US)

Announcement Regarding Submission of Tender Offer for Shares in Ambit Biosciences Corporation

Announcement Regarding Submission of Tender Offer for Shares in Ambit Biosciences Corporation PR Newswire TOKYO and SAN DIEGO, Oct. 14, 2014 TOKYO and SAN DIEGO, Oct. 14, 2014 /PRNewswire/ -- On...

14 Octubre 2014
PR Newswire (US)

Daiichi Sankyo to Acquire Ambit Biosciences

Daiichi Sankyo to Acquire Ambit Biosciences Lead Compound, Quizartinib, Will Further Build Daiichi Sankyo Oncology Pipeline PR Newswire TOKYO and SAN DIEGO, Sept. 29, 2014 TOKYO and SAN DIEGO...

29 Septiembre 2014
PR Newswire (US)

Daiichi Sankyo to Acquire Ambit Biosciences

Daiichi Sankyo to Acquire Ambit Biosciences PR Newswire TOKYO and SAN DIEGO, Sept. 29, 2014 -- Lead Compound, Quizartinib, Will Further Build Daiichi Sankyo Oncology Pipeline TOKYO and SAN DIEGO...

28 Septiembre 2014
PR Newswire (US)

Daiichi Sankyo to Acquire Ambit Biosciences

Daiichi Sankyo to Acquire Ambit Biosciences Lead Compound, Quizartinib, Will Further Build Daiichi Sankyo Oncology Pipeline PR Newswire TOKYO and SAN DIEGO, Sept. 28, 2014 TOKYO and SAN DIEGO...

28 Septiembre 2014
PR Newswire (US)

Daiichi Sankyo Further Expands TaNeDS Collaborative Drug Discovery Program in Europe

Daiichi Sankyo Further Expands TaNeDS Collaborative Drug Discovery Program in Europe PR Newswire TOKYO, Sept. 1, 2014 TOKYO, Sept. 1, 2014 /PRNewswire/ -- Daiichi Sankyo Company, Limited (Tokyo...

02 Septiembre 2014
PR Newswire (US)

Daiichi Sankyo Further Expands TaNeDS Collaborative Drug Discovery Program in Europe

Daiichi Sankyo Further Expands TaNeDS Collaborative Drug Discovery Program in Europe PR Newswire TOKYO, Sept. 1, 2014 TOKYO, Sept. 1, 2014 /PRNewswire/ -- Daiichi Sankyo Company, Limited (Tokyo...

31 Agosto 2014
PR Newswire (US)

Daiichi Sankyo and Charleston Laboratories Announce Collaboration to Develop and Commercialize Novel, Fixed-Dose Combination ...

Daiichi Sankyo and Charleston Laboratories Announce Collaboration to Develop and Commercialize Novel, Fixed-Dose Combination Hydrocodone Products for Pain and Opioid-Induced Nausea and Vomiting...

06 Agosto 2014
PR Newswire (US)
Período †Variación(Ptos)Variación %AperturaPrecio MáximoPrecio MínimoAvg. Vol. diarioPrecio Promedio Ponderado
10.51.8587360594826.927.9826.814475327.36839238DR
4-3.25-10.60358890730.6530.726.822160827.91431631DR
12-5.49-16.692003648532.8934.1926.814341829.59675485DR
26-8.6-23.88888888893642.4826.89723532.00883474DR
520.542.0104244229326.8642.4826.812356432.21145046DR
1563.4514.405010438423.9542.4819.3912589930.1822449DR
260-37.64-57.872078720865.0499.6318.058827430.48429751DR

DSNKY - Preguntas Frecuentes

¿Cuál es el precio actual de las acciones de Daiichi Sankyo (PK)?
El precio actual de las acciones de Daiichi Sankyo (PK) es US$ 27.40
¿Cuál es el rango de negociación de 1 año para el precio de las acciones de Daiichi Sankyo (PK)?
Daiichi Sankyo (PK) ha negociado en un rango de US$ 26.80 a US$ 42.48 durante el último año

Movimientos

Ver todo
  • Volumen
  • % Mayores Alzas
  • % Mayores Bajas
SímboloPrecioVol.
AABVFAberdeen International Inc (PK)
US$ 0.0242
(0.00%)
0
AABKFAareal Bank AG (PK)
US$ 0.00
(0.00%)
0
AABBAsia Broadband Inc (PK)
US$ 0.02155
(0.00%)
0
AAALYAareal Bank AG (PK)
US$ 34.65
(0.00%)
0
AAAIFAlternative Investment Trust (PK)
US$ 0.55
(0.00%)
0
AABVFAberdeen International Inc (PK)
US$ 0.0242
(0.00%)
0
AABKFAareal Bank AG (PK)
US$ 0.00
(0.00%)
0
AABBAsia Broadband Inc (PK)
US$ 0.02155
(0.00%)
0
AAALYAareal Bank AG (PK)
US$ 34.65
(0.00%)
0
AAAIFAlternative Investment Trust (PK)
US$ 0.55
(0.00%)
0
AABVFAberdeen International Inc (PK)
US$ 0.0242
(0.00%)
0
AABKFAareal Bank AG (PK)
US$ 0.00
(0.00%)
0
AABBAsia Broadband Inc (PK)
US$ 0.02155
(0.00%)
0
AAALYAareal Bank AG (PK)
US$ 34.65
(0.00%)
0
AAAIFAlternative Investment Trust (PK)
US$ 0.55
(0.00%)
0

Discusión

Ver feed completo
Uncle Monkey Uncle Monkey 3 minutos hace
so FSar today????
CBRF
Zadie420 Zadie420 3 minutos hace
Check your browser. I can see it in my laptop as well as my phone.
CKPT
BlazingStocks BlazingStocks 3 minutos hace
$ILLR News December 20, 2024

Triller Group Inc. Unveils Bold Vision and Exciting Business Updates During Investor Day
https://finance.yahoo.com/news/triller-group-inc-unveils-bold-140000772.html
ILLR
Drugdoctor Drugdoctor 3 minutos hace
$MEGL $1.73 +207%
MEGL
sam1933 sam1933 3 minutos hace
Pluton is getting close to "buy all you can" IMO
PLUUSD
hyborianwar hyborianwar 4 minutos hace
6.35 is monthly breakout 🙈
FNMA
extrinsic55 extrinsic55 5 minutos hace
SGBX ask .58 ClimbContinues7thDaySlowUPUP
SGBX
extrinsic55 extrinsic55 6 minutos hace
SGBX ask .58 ClimbContinues7thDaySlowUPUP
SGBX
extrinsic55 extrinsic55 6 minutos hace
SGBX ask .58 ClimbContinues7thDaySlowUPUP
SGBX
Freddie bagholder Freddie bagholder 7 minutos hace
Boom!!! $49.95 incoming!!!
FNMA
ddls ddls 8 minutos hace
There' no value in BIEL, NONE!😎
BIEL
StayHumble StayHumble 8 minutos hace
$AMC Silver investments Golden💹wow! ShortFilmXplosion Coming💹
AMC
RIGATONI RIGATONI 10 minutos hace
.77 new high ~Rig


































SPRC
RIGATONI RIGATONI 10 minutos hace
.14 new high off Friday ~Rig
oldstocks oldstocks 11 minutos hace
MEGL moving
MEGL
RIGATONI RIGATONI 11 minutos hace
Good morning! ~Rig
Just the facts maam Just the facts maam 12 minutos hace
Silvr, selling part of the company would require shareholder approval. However, a spinning-off the company as a dividend does not appear to require shareholder approval. This could be done quickly.
ANIP
misterfishman misterfishman 12 minutos hace
That's why I only got fifty bucks worth of shares so no biggie here it was only a very small taste.
GMPR
sam1933 sam1933 13 minutos hace
⁉️ Which Crypto ETF Will Be Approved First in 2025?

Litecoin and Hedera ETFs Seen as Frontrunners ‼️
Bloomberg analysts Eric Balchunas and James Seyffart predict that crypto ETFs such as Litecoin and Hedera ETFs are more likely to gain approval b
HBARUSD
thesmallguy thesmallguy 15 minutos hace
That's the hope.
ASII
Penny2Dime Penny2Dime 15 minutos hace
Looks great!
IRBT
Iggy_Bot Iggy_Bot 21 minutos hace
Remember that old commercial .. Joe could learn a lot from a Justin ... maybe i have it wrong :)
LTListener LTListener 22 minutos hace
Interesting reply in that specifically noted is the seperation of assets/efforts with ResolutionRx and that of RespireRx. Suggestive that there is an overarching plan in place for RespireRx assets not to be intertwined with the OSA program of ResolutionRx. Logical as it fits their commentary in fi
RSPI
thistraderknowsall thistraderknowsall 24 minutos hace
ZENA surges to $50 on latest news!
Keep your eye on this military contracts
Are sendingnit to moon!!!

ZenaTech Opens a Beyond Visual Line of Sight (BVLOS) Drone Testing Facility in Turkey for US Defense and NATO-Destined ZenaDrone 1000 Drones

Su Consulta Reciente

USOTC
DSNKY
Daiichi Sankyo (PK)
USOTC
CPXWF
Capital Power (PK)
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2025 ADVFN PLC - Todos los derechos reservados